Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

632 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B.
van Bömmel F, Stein K, Heyne R, Petersen J, Buggisch P, Berg C, Zeuzem S, Stallmach A, Sprinzl M, Schott E, Pathil-Warth A, von Arnim U, Keitel V, Lohmeyer J, Simon KG, Trautwein C, Trein A, Hüppe D, Cornberg M, Lammert F, Ingiliz P, Zachoval R, Hinrichsen H, Zipprich A, Klinker H, Schulze Zur Wiesch J, Schmiedeknecht A, Brosteanu O, Berg T. van Bömmel F, et al. Among authors: lammert f. J Hepatol. 2023 May;78(5):926-936. doi: 10.1016/j.jhep.2022.12.018. Epub 2023 Mar 28. J Hepatol. 2023. PMID: 37062574 Free article. Clinical Trial.
[Costs of potentially outpatient endoscopic procedures in cases with a 1-day hospital stay versus a longer stay].
Rathmayer M, Heinlein W, Wagner T, Lerch MM, Lammert F, Dollhopf M, Haag C, Gölder SK, Kandulski A, Schad M, Schmidt A, Gundling F, Wilke M, Albert JG; für die DRG-Projektgruppe der DGVS*. Rathmayer M, et al. Among authors: lammert f. Z Gastroenterol. 2023 May;61(5):504-514. doi: 10.1055/a-2016-9196. Epub 2023 Mar 9. Z Gastroenterol. 2023. PMID: 36893789 German.
Screening for liver fibrosis: lessons from colorectal and lung cancer screening.
Thiele M, Kamath PS, Graupera I, Castells A, de Koning HJ, Serra-Burriel M, Lammert F, Ginès P. Thiele M, et al. Among authors: lammert f. Nat Rev Gastroenterol Hepatol. 2024 Mar 13. doi: 10.1038/s41575-024-00907-2. Online ahead of print. Nat Rev Gastroenterol Hepatol. 2024. PMID: 38480849 Review.
Dual role of GRHL3 in bladder carcinogenesis depending on histological subtypes.
Lammert FC, Pannhausen J, Noetzel E, Friedland F, Wirtz J, Herfs Y, Leypold S, Gan L, Weiskirchen R, Schnitzler T, Knüchel R, Maurer J, Jonigk DD, Rose M, Gaisa NT. Lammert FC, et al. Mol Oncol. 2024 Mar 2. doi: 10.1002/1878-0261.13623. Online ahead of print. Mol Oncol. 2024. PMID: 38429970 Free article.
Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis.
Salzmann RJS, Krötz C, Mocan T, Mocan LP, Grapa C, Rottmann S, Reichelt R, Keller CM, Langhans B, Schünemann F, Pohl A, Böhler T, Bersiner K, Krawczyk M, Milkiewicz P, Sparchez Z, Lammert F, Gehlert S, Gonzalez-Carmona MA, Willms A, Strassburg CP, Kornek MT, Dold L, Lukacs-Kornek V. Salzmann RJS, et al. Among authors: lammert f. Hepatol Commun. 2024 Feb 14;8(3):e0380. doi: 10.1097/HC9.0000000000000380. eCollection 2024 Mar 1. Hepatol Commun. 2024. PMID: 38358371 Free PMC article.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
632 results